NIRAPARIB for Cholangiocarcinoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 19 adverse event reports in the FDA FAERS database where NIRAPARIB was used for Cholangiocarcinoma.

Most Reported Side Effects for NIRAPARIB

Side Effect	Reports	%	Deaths	Hosp.
Nausea	5,794	26.8%	182	1,368
Fatigue	5,240	24.2%	146	1,181
Constipation	4,128	19.1%	108	984
Platelet count decreased	4,102	19.0%	124	1,186
Insomnia	2,861	13.2%	57	571
Blood pressure increased	2,464	11.4%	51	545
Headache	2,383	11.0%	38	507
Off label use	2,213	10.2%	114	448
Vomiting	2,029	9.4%	101	711
Carbohydrate antigen 125 increased	1,868	8.6%	44	409
Decreased appetite	1,865	8.6%	101	557
Asthenia	1,862	8.6%	73	631
Product dose omission issue	1,852	8.6%	35	443
Haemoglobin decreased	1,759	8.1%	51	522
Dizziness	1,596	7.4%	33	399